Patents by Inventor David Bertil Frennesson

David Bertil Frennesson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anhydro sugar derivatives of indolocarbazoles
    Patent number: 6686385
    Abstract: The present invention concerns novel sugar derivatives of indolocarbazoles and pharmaceutical formulations thereof which exhibit topoisomerase-I activity and are useful in inhibiting the proliferation of tumor cells.
    Type: Grant
    Filed: May 7, 2003
    Date of Patent: February 3, 2004
    Assignee: Bristol-Myers Squibb Company
    Inventors: Mark G. Saulnier, Edward H. Ruediger, Neelakantan Balasubramanian, David Bertil Frennesson, Mikael Mahler, Kurt Zimmermann
  • ANHYDRO SUGAR DERIVATIVES OF INDOLOCARBAZOLES
    Publication number: 20030220387
    Abstract: The present invention concerns novel sugar derivatives of indolocarbazoles and pharmaceutical formulations thereof which exhibit topoisomerase-I activity and are useful in inhibiting the proliferation of tumor cells.
    Type: Application
    Filed: May 7, 2003
    Publication date: November 27, 2003
    Applicant: Bristol-Myers Squibb Company
    Inventors: Mark G. Saulnier, Edward H. Ruediger, Neelakantan Balasubramanian, David Bertil Frennesson, Mikael Mahler, Kurt Zimmermann
  • Anhydro sugar derivatives of indolocarbazoles
    Patent number: 6610727
    Abstract: The present invention concerns novel sugar derivatives of indolocarbazoles and pharmaceutical formulations thereof which exhibit topoisomerase-1 activity and are useful in inhibiting the proliferation of tumor cells.
    Type: Grant
    Filed: September 27, 2001
    Date of Patent: August 26, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: Mark G. Saulnier, Edward H. Ruediger, Neelakantan Balasubramanian, David Bertil Frennesson, Mikael Mahler, Kurt Zimmermann
  • Anhydro sugar derivatives of indolocarbazoles
    Publication number: 20020111375
    Abstract: The present invention concerns novel sugar derivatives of indolocarbazoles and pharmaceutical formulations thereof which exhibit topoisomerase-I activity and are useful in inhibiting the proliferation of tumor cells.
    Type: Application
    Filed: September 27, 2001
    Publication date: August 15, 2002
    Inventors: Mark G. Saulnier, Edward H. Ruediger, Neelakantan Balasubramanian, David Bertil Frennesson, Mikael Mahler, Kurt Zimmermann